Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, AVO

Virtual Care Up, Stethoscope Tests Down: Experts Concerned About Risk of Undiagnosed Heart Valve Disease


TORONTO, July 7, 2021 /CNW/ - Although many Canadians have been seeing their GPs virtually since March 2020 and intend to continue with virtual care for non-emergency appointments, three-quarters of respondents aged 25 and older to a national survey released today, believe the virtual visit is not as effective as in-person appointments in discovering new or worsening symptoms.  61% of those surveyed say they have not had a stethoscope check, a key diagnostic tool for uncovering heart valve disease, for more than one year.

"We have several factors converging that stand to result in a potentially significant health issue: an increase in virtual care during the pandemic and for the foreseeable future, too few stethoscope tests, and an aging population with very low awareness about heart valve disease symptoms who frequently discount symptoms because they often mimic the general signs of aging," says Dr. Charles Peniston, Cardiovascular Surgeon, former Division Head and Medical Director, Southlake Regional Health Centre and Chair of Heart Valve Voice Canada.

The survey, commissioned by Heart Valve Voice Canada (HVVC), a national non-profit patient advocacy organization that works to improve the health and quality of life of people living with heart valve disease, was conducted through Leger's online panel of 550 Canadians aged 25-plus, found:

"Virtual care plays an important role in healthcare delivery, but it has its shortcomings. We've got to help Canadians balance the benefits and ease of virtual care with also making sure to have their heart listened to. This is especially important when you factor in population health studies which show the prevalence of heart valve disease and the fact that many people with heart valve disease do not have symptoms. A stethoscope test arms GPs with that incremental knowledge," Peniston adds.

The survey also found:

Heart valve disease is a common, serious, but treatable condition that affects approximately 1.1 million people in Canada.  A first of its kind population-based study, aimed specifically at the community detection of heart valve disease found over 50% of newly detected cases of valve disease in a population that did not have symptoms of the disease. It revealed that more than half of persons with heart valve disease in the general population were not detected and thus do not know they had the disease.1 If diagnosed and treated early, people can return to a good quality of life. Detection of heart valve disease involves identifying a heart murmur using a stethoscope followed by an echocardiogram to confirm the diagnosis.

In addition to its Symptom Tracker, HVVC recently unveiled a Virtual Appointment Guide designed to help Canadians and their caregivers identify and convey potentially concerning symptoms during virtual appointments and bring potential warning signs to the attention of their healthcare provider or in the case of an emergency, encourage patients to go to their local hospital Emergency Department. With an increase in caregivers across Canada, one of the Virtual Guide's Top Tips is the suggestion Canadians talk about their health with someone they're close to.

Established in 2018 Heart Valve Voice Canada is a national non-profit patient advocacy organization that works to improve the health and quality of life with people living with heart valve disease.

Editor's Notes regarding surgical advances and available patients who underwent procedures during the pandemic:

While the pandemic has had an unprecedented global effect on health care including the cancellation and delay of cardiac catheterizations, interventions, and surgeries, as confirmed by an international study of 60 centres around the world2, treatment including innovative procedures continued for patients with heart valve disease including at Ontario's Southlake Regional Health Centre.

John Hartill, 85 from Bracebridge, ON is among the first patients in Ontario to undergo a breakthrough, minimally invasive TAVI (transcatheter aortic valve implantation) procedure using the carotid artery in the neck as an entry point instead of the usual femoral artery access in the groin. This innovation means more Canadians now have access to a potentially live-saving procedure.

Dave Smith, 63 from Mono Mills, ON visited his local ER during COVID-19. Diagnosed with severe aortic stenosis, he received a surgical aortic valve replacement (SAVR) during the pandemic, September 2020.

About the Survey:

An online survey of 550 Canadians who identify as current and future caregivers aged 25+ as well as non-caregivers aged 65-plus, was completed between June 4-6, 2021, using Leger's online panel.

  1. The OxVALVE Population Cohort Study. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study - PubMed (nih.gov)
  2. Response of Cardiac Surgery Units to COVID-19. An Internationally Based Quantitative Survey Mario Gaudino, Joanna Chikwe, Irbaz Hameed, N. Bryce Robinson, Stephen E. Fremes, Marc Ruel. Originally published11 May 2020

 

SOURCE Heart Valve Voice Canada


These press releases may also interest you

at 10:30
Omni Quality Living ("Omni"), a portfolio business of The Hillcore Group, a leader in long-term care and senior living, is pleased to announce effective July 2nd, 2024, it has assumed the management of five high-quality long-term care homes located...

at 10:11
The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024. A distinguished medical researcher, Dr. Nemer has served as Canada's...

at 10:10
The "TechVision50: Top 50 Advanced and Emerging Technologies" report has been added to ResearchAndMarkets.com's offering. TechVision50 is a guide of the 50 greatest opportunities in Advanced Technologies and Materials at the mid-point of 2024. This...

at 10:10
The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral...

at 10:05
The "The Worldwide Market for Clinical Laboratory Services, 9th Edition" report has been added to ResearchAndMarkets.com's offering. Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers...

at 10:00
The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug...



News published on and distributed by: